XML 71 R37.htm IDEA: XBRL DOCUMENT v3.19.1
LICENSE AGREEMENTS (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2013
Assets Sold under Agreements to Repurchase [Line Items]        
Milestone fee free sales target value     $ 1,500,000,000  
Royalties payment expiration requirement 10 years      
Milestone and royalty fee $ 0 $ 0    
Alba Agreement        
Assets Sold under Agreements to Repurchase [Line Items]        
License fees     500,000  
Maximum Potential Future Clinical And Regulatory Milestone Payment     1,500,000  
Sales range, minimum     100,000,000  
Sales range, maximum     1,500,000,000  
Seachaid Agreement        
Assets Sold under Agreements to Repurchase [Line Items]        
License fees       $ 200,000
Maximum Potential Future Clinical And Regulatory Milestone Payment       6,000,000
License and Service | Alba Agreement        
Assets Sold under Agreements to Repurchase [Line Items]        
License and service revenue     150,000,000  
License | Alba Agreement        
Assets Sold under Agreements to Repurchase [Line Items]        
Cost of goods sold     $ 2,500,000  
Minimum | Seachaid Agreement        
Assets Sold under Agreements to Repurchase [Line Items]        
Potential Future Commercial Milestone Payment       1,000,000
Maximum | Seachaid Agreement        
Assets Sold under Agreements to Repurchase [Line Items]        
Potential Future Commercial Milestone Payment       $ 2,500,000